See how we’re changing pathology
For 150 years, cancer diagnosis has been limited to the subjective interpretation of what the human eye could see under a microscope. To change the way we diagnose and research cancer, we need new tools — computational applications that leverage AI and machine learning — to show us the information hidden in every tissue sample.
That’s why we started Proscia. Our mission is to perfect cancer diagnosis with intelligent software that changes the way the world practices pathology. We’re building tools for the mind that are redefining pathology and giving pathologists better ways to fight cancer today.
Making History
We founded Proscia with a vision for what pathology could become. With the support of forward-thinking partners, investors, and laboratories, our vision is rapidly becoming a reality.
July, 2014
Proscia founded in 2014 by a team out of Johns Hopkins and the University of Pittsburgh
May, 2015
Proscia launches first version of its Concentriq digital pathology software platform
June, 2017
Proscia recognized as a leader in digital pathology technology by Frost and Sullivan
September, 2017
Proscia enters the commercial and hospital lab market, transforming the clinical use of digital pathology
September, 2018
Proscia closes Series A round of financing
November, 2018
Proscia founders included in the Forbes 30 Under 30 list
June, 2019
Proscia releases DermAI – its first computational pathology application for dermatopathology
November, 2019
Proscia's Concentriq Dx receives CE Mark for primary diagnosis
October, 2020
Joint Pathology Center selects Concentriq to modernize the world's largest human tissue repository.
December, 2020
Proscia closes $23M Series B round to accelerate global growth.
Company Highlights
- Founded in Baltimore, MD in 2014
- Headquarters in Philadelphia, PA
- 6 major academic research centers partner with Proscia
- 5,000+ pathologists and scientists use Concentriq
- Collaborating with 12+ clinical AI partners with access to over 1M whole slide images for AI research
- Integration with all major whole slide image scanners and LIS applications
- 4 U.S. patents granted
- $35.3M raised to date
Featured In
Funded By
Partners Against Cancer
At Proscia, the patient remains the driving force behind our mission. We are proud to work with the American Cancer Society as a Partner Against Cancer to help improve access to treatment for those who need it. Proscia has made a commitment to the ACS Hope Lodge Program, an important initiative that provides free lodging for patients in more than 30 locations across the United States and Puerto Rico.
Partner with Proscia
With a unified laboratory ecosystem, Concentriq is driving economic and clinical value for a growing list of hardware and software partners. See what kind of opportunities we can unlock for your company.
Join the fight against cancer
A career at Proscia means effecting real change for pathologists and the way humans understand and diagnose cancer. Bring your passion to a workplace where nothing is impossible.